Animal models of traumatic brain injury - PubMed (original) (raw)
Review
Animal models of traumatic brain injury
Ye Xiong et al. Nat Rev Neurosci. 2013 Feb.
Abstract
Traumatic brain injury (TBI) is a leading cause of mortality and morbidity both in civilian life and on the battlefield worldwide. Survivors of TBI frequently experience long-term disabling changes in cognition, sensorimotor function and personality. Over the past three decades, animal models have been developed to replicate the various aspects of human TBI, to better understand the underlying pathophysiology and to explore potential treatments. Nevertheless, promising neuroprotective drugs that were identified as being effective in animal TBI models have all failed in Phase II or Phase III clinical trials. This failure in clinical translation of preclinical studies highlights a compelling need to revisit the current status of animal models of TBI and therapeutic strategies.
Figures
Figure 1. Experimental set ups for the animal models of traumatic brain injury
a ∣ The fluid percussion injury (FPI) device uses rapid injection of a fluid pulse into the epidural space. b ∣ The controlled cortical impact (CCI) model uses an air or electromagnetic driven piston to penetrate the brain at a known distance and velocity. c ∣ The penetrating ballistic-like brain injury (PBBI) involves the transmission of projectiles with high energy of a metal rod or expansion of the probe’s elastic balloon. d ∣ In the Feeney weight-drop model, a free weight is released directly onto the exposed dura. e ∣ In the Marmarou weight-drop model, a metal disk is placed over the skull to prevent bone fracture. f ∣ The blast brain injury caused by primary injury of blast or other mechanisms, e.g., thoracic effect. Panels a,b,d,e are modified, with permission, from REF. [54]© 2003 Mary Ann Liebert, Inc. Publishers. Panel c is modified, with permission, from REF [55]© 2007 Mary Ann Liebert, Inc. Publishers.
Similar articles
- Chapter 3 animal models of traumatic brain injury: is there an optimal model that parallels human brain injury?
Briones TL. Briones TL. Annu Rev Nurs Res. 2015;33:31-73. doi: 10.1891/0739-6686.33.31. Annu Rev Nurs Res. 2015. PMID: 25946383 Review. - Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?
Marklund N, Hillered L. Marklund N, et al. Br J Pharmacol. 2011 Oct;164(4):1207-29. doi: 10.1111/j.1476-5381.2010.01163.x. Br J Pharmacol. 2011. PMID: 21175576 Free PMC article. Review. - A mouse model of blast-induced mild traumatic brain injury.
Rubovitch V, Ten-Bosch M, Zohar O, Harrison CR, Tempel-Brami C, Stein E, Hoffer BJ, Balaban CD, Schreiber S, Chiu WT, Pick CG. Rubovitch V, et al. Exp Neurol. 2011 Dec;232(2):280-9. doi: 10.1016/j.expneurol.2011.09.018. Epub 2011 Sep 17. Exp Neurol. 2011. PMID: 21946269 Free PMC article. - Animal models of traumatic brain injury: a review of pathophysiology to biomarkers and treatments.
Petersen A, Soderstrom M, Saha B, Sharma P. Petersen A, et al. Exp Brain Res. 2021 Oct;239(10):2939-2950. doi: 10.1007/s00221-021-06178-6. Epub 2021 Jul 29. Exp Brain Res. 2021. PMID: 34324019 Review. - Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention.
Kumar A, Loane DJ. Kumar A, et al. Brain Behav Immun. 2012 Nov;26(8):1191-201. doi: 10.1016/j.bbi.2012.06.008. Epub 2012 Jun 21. Brain Behav Immun. 2012. PMID: 22728326 Review.
Cited by
- Characteristic of clinical trials related to traumatic brain injury registered on ClinicalTrials.gov over the past two decades (2004-2023).
Guo R, Yang Q, Zhou X, Li S, Liu Y. Guo R, et al. Front Med (Lausanne). 2024 Sep 16;11:1435762. doi: 10.3389/fmed.2024.1435762. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39351009 Free PMC article. - Roles of HMGB1 on life-threatening traumatic brain injury and sequential peripheral organ damage.
Kawai C, Miyao M, Kotani H, Minami H, Abiru H, Tamaki K, Nishitani Y. Kawai C, et al. Sci Rep. 2024 Sep 13;14(1):21421. doi: 10.1038/s41598-024-72318-x. Sci Rep. 2024. PMID: 39271757 Free PMC article. - Organoids and chimeras: the hopeful fusion transforming traumatic brain injury research.
Bellotti C, Samudyata S, Thams S, Sellgren CM, Rostami E. Bellotti C, et al. Acta Neuropathol Commun. 2024 Aug 30;12(1):141. doi: 10.1186/s40478-024-01845-5. Acta Neuropathol Commun. 2024. PMID: 39215375 Free PMC article. Review. - Selective COX-2 Inhibitors as Neuroprotective Agents in Traumatic Brain Injury.
Hiskens MI, Schneiders AG, Fenning AS. Hiskens MI, et al. Biomedicines. 2024 Aug 22;12(8):1930. doi: 10.3390/biomedicines12081930. Biomedicines. 2024. PMID: 39200394 Free PMC article. Review. - Acute and Reversible Hypothalamic Symptoms in a Lateral Head Impact Mouse Model of Mild Traumatic Brain Injury.
O'Reilly-Fong J, Simpson NJ, Thirouin ZS, Bastone PA, Zaelzer C, Murtaz A, Bourque CW. O'Reilly-Fong J, et al. Neurotrauma Rep. 2024 Aug 8;5(1):749-759. doi: 10.1089/neur.2024.0071. eCollection 2024. Neurotrauma Rep. 2024. PMID: 39184177
References
- Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7:728–741. - PubMed
- Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil. 2006;21:375–378. - PubMed
- Masel BE, DeWitt DS. Traumatic brain injury: a disease process, not an event. J Neurotrauma. 2010;27:1529–1540. - PubMed
- Muir KW. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Curr Opin Pharmacol. 2006;6:53–60. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 NS023393/NS/NINDS NIH HHS/United States
- P01 NS042345/NS/NINDS NIH HHS/United States
- P50 NS023393/NS/NINDS NIH HHS/United States
- R01 NS062002/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous